Business

The company will be subject to a 12-month follow-up review period to assure that it does not fall below NYSE standards.

The company will use the funds to accelerate its product expansion on a global scale.

The Series A funding announcement comes less than a month after the company announced integration capabilities with AWS, Google Cloud, Databricks and Snowflake.

The modernized, outcomes-focused AMAM is meant to help health systems keep pace with the rapid evolution of analytics technologies and artificial intelligence and "support equitable, data-driven decision-making at scale."  

The company will use the funds to expand its partnerships with Athena, Oracle Cerner, Epic and MEDITECH, and to enhance its offerings, Suki Assistant and Suki Platform.

SPRY Therapeutics, an AI-enabled physical therapy platform, and Every Cure, an AI-powered biotech organization, also secured funds.

The acquisition allows Resilience Lab to integrate Options MD's medication management and psychotherapy offerings for individuals with severe mental illness.

The aim is to expand Hello Heart's reach across patient populations by utilizing the Amwell platform. 

A potentially shortened battery life in the MiniMed 600 or 700 series insulin pumps may result in the pump stopping insulin delivery significantly sooner than expected.

The seed-funding round will be used to expand the company's addiction and support recovery app.